Related Experiment Video
Updated: Aug 23, 2025

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
The impact of Hounsfield unit-related variables on percutaneous nephrolithotomy outcomes
Hyong Woo Moon1, Mustafa Taeyb1,2, Yong Hyun Park1
1Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-Daero, Seocho-Gu, Seoul, 06591, Republic of Korea.
Insights
Hounsfield Unit/Cross-sectional Area (HU/CSA) ratio, not Hounsfield Units alone, predicts percutaneous nephrolithotomy (PCNL) success for kidney stones. This metric aids in planning treatments and predicting outcomes for stone removal.
Area of Science:
- Urology
- Nephrolithiasis Management
- Medical Imaging
Background:
- Percutaneous nephrolithotomy (PCNL) is a key treatment for kidney stones.
- Predicting PCNL outcomes is crucial for patient management.
- Hounsfield Units (HU) from CT scans are used to characterize stones, but their direct association with PCNL outcomes requires further investigation.
Purpose of the Study:
- To investigate the association between Hounsfield Unit (HU)-related variables and percutaneous nephrolithotomy (PCNL) outcomes.
- To determine if specific CT-derived stone characteristics can predict stone-free status after PCNL.
Main Methods:
- Retrospective review of 188 patients with single renal stones (1-3 cm) undergoing single-tract PCNL.
- Analysis of preoperative and follow-up CT scans to assess stone-free status (residual stone ≤ 2 mm within 3 months).
- Measurement of stone Hounsfield Units (HU) and Cross-sectional Area (CSA); logistic regression analysis of HU-related variables.
Main Results:
- The overall stone-free rate (SFR) was 79.2%.
- No significant differences were found in age, sex, BMI, stone size, or HU between stone-free and remnant groups.
- The HU/CSA ratio was significantly different between the stone-free (10.1 ± 5.6) and remnant (7.3 ± 3.4) groups (p=0.001), while CSA differed significantly (p=0.043).
Conclusions:
- The HU/CSA ratio, not HU alone, is an independent predictor of stone-free status after PCNL.
- Pelvic and ureteropelvic junction stones were also identified as predictors of SFR.
- The HU/CSA ratio shows potential for guiding kidney stone treatment decisions and predicting PCNL outcomes.
Abstract:
We aimed to identify the association between Hounsfield Unit(HU)-related variables and percutaneous nephrolithotomy (PCNL) outcomes. We enrolled patients with single renal stones (1-3 cm) who underwent single-tract PCNL between January 2014 and October 2019. Demographics and stone characteristics were retrospectively reviewed. Preoperative computerized tomography (CT) and follow-up CT within at least 3 months after PCNL were included in this analysis. Stone-free status was defined as residual stone measuring ≤ 2 mm within 3 months postoperatively. HU and cross-sectional area (CSA) were measured using the free-draw technique. We analyzed HU-related variables using logistic regression model for outcomes. Altogether, 188 out of 683 patients met the inclusion criteria. The stone-free rate (SFR) was 79.2%. There were no significant differences in age, sex, BMI, ASA class, laterality, pre-op shockwave lithotripsy, stone size, stone burden, skin-to-stone distance, and HU between the stone-free and remnant groups. CSA and HU/CSA in the stone-free and remnant groups were 94.5 ± 46.1 and 128.3 ± 98.5 (p = 0.043) and 10.1 ± 5.6 and 7.3 ± 3.4 (p = 0.001), respectively. Multivariate logistic regression analysis revealed that pelvis, ureteropelvic junction stones, and HU/CSA were independent predictors of SFR. HU did not affect PCNL outcomes. We believe that HU/CSA could be used for determining stone treatment plans and predicting outcomes.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Urinary Tract Calculi III: Medical Management
Cardiac Catheterization I: Pre-Procedure Overview
Urinary Tract Calculi V: Nursing Management

